Company: Canntab Therapeutics Limited
CEO: Jeff Renwick, CEO & Richard Goldstein, CFO
Symbol: PILL.CNX
Slider Deck:  Click Here

Requesting An Investor Package

Schedule Appointment

Canntab Therapeutics Limited Elevator Pitch

 Interview Presentation Information

Canntab Therapeutics Limited has a clear vision to become a leader in oral dosage cannabis, with unique products that offer advantages to the medical community, patients, adult use consumers and governments.


• Clear and Sustainable Competitive Advantage Through Robust Intellectual Property with 13 patents pending.
• Well financed, publicly traded on the CSE (:PILL).
• We’ve created valuable licensing and joint venture deals in Canada and international markets, such as Australia and Germany.
• We’re launching our first two products under the 420 Therapeutics brand in the coming months.
• Along with our Canadian licensing partner, Emblem, we’ve received Health Canada approval for the development and clinical trials of our breakthrough Extended Release (XR) Tablets.
• Robust new product development, including the development of 420 Therapeutics, with the goal to be a leader in the wellness category.
• Established Leadership with a Track Record of Driving Value.

Head Office:
223 Riviera Drive, Suite 2702
Markham, ON
L3R 5J6
Telephone: (289) 301-3812

Leave a Comment

Your email address will not be published. Required fields are marked *

Get Access to The Richmond Clubs Latest Stock Picks For FREE!


Don’t miss your chance to get in on the top stocks we think are the best buys now inside our exclusive Richmond Club Stock Advisor Letter.

Led by Chartered Investment Manager, Greg Beckett, the average stock pick inside The Richmond Club is up 1,301% vs. just 153% for the S&P.

This is your opportunity to become part of an exclusive membership led by the Richmond Club that has seen an average of 16.45 % gains over the past 15 years!

If you want to take advantage of this buying opportunity, simply enter your email address below to access our secure sign-up page.

Join The Richmond Advisor Free For 2-Months

By submitting your email address, you consent to us keeping you informed about updates to our website and about other products and services that we think might interest you. You can unsubscribe at any time. Please read our Privacy Policy